{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:33:37Z","timestamp":1791113617393,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,27]]},"DOI":"10.1097\/01.tp.0000137793.23371.42","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T09:28:36Z","timestamp":1098178116000},"page":"1204-1211","source":"Crossref","is-referenced-by-count":76,"title":["Calcium Channel Blockade and Preservation of Renal Graft Function in Cyclosporine-Treated Recipients: A Prospective Randomized Placebo-Controlled 2-Year Study"],"prefix":"10.1097","volume":"78","author":[{"given":"D R. J.","family":"Kuypers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H H.","family":"Neumayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L.","family":"Rodicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5, Suppl 2","key":"R1-22-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","article-title":"Hypertension after renal transplantation.","volume":"21","author":"Ponticelli","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R2-22-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy.","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"R3-22-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Collaborative Transplant Study: association of chronic kidney graft failure with recipient blood pressure.","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"issue":"Suppl 6","key":"R4-22-20210129","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00007890-200109271-00004","article-title":"Mechanisms and consequences of arterial hypertension after renal transplantation.","volume":"72","author":"Koomans","year":"2001","journal-title":"Transplantation"},{"key":"R5-22-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","article-title":"Cyclosporine-induced dysfunction in the rat: evidence of arteriolar vasoconstriction with preservation of tubular function.","volume":"44","author":"English","year":"1987","journal-title":"Transplantation"},{"key":"R6-22-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1523-1755.1998.00852.x","article-title":"Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction-mediated vasoconstriction in rats.","volume":"53","author":"Cavarape","year":"1998","journal-title":"Kidney Int"},{"key":"R7-22-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(99)00447-1","article-title":"Cyclosporine A induces prepro endothelin-1 gene transcription in human endothelial cells.","volume":"379","author":"Marsen","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R8-22-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199009133231101","article-title":"Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.","volume":"323","author":"Scherrer","year":"1990","journal-title":"N Engl J Med"},{"key":"R9-22-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00007890-198907000-00027","article-title":"Altered vascular responses in cyclosporine-treated rats.","volume":"48","author":"Golub","year":"1989","journal-title":"Transplantation"},{"key":"R10-22-20210129","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/00007890-199312000-00029","article-title":"Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.","volume":"56","author":"Smith","year":"1993","journal-title":"Transplantation"},{"key":"R11-22-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.1992.27","article-title":"Effects of thromboxane synthase inhibition with CGS13080 in human cyclosporine nephrotoxicity.","volume":"41","author":"Smith","year":"1992","journal-title":"Kidney Int"},{"key":"R12-22-20210129","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1074\/jbc.275.5.3075","article-title":"Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1.","volume":"275","author":"Navarro-Antolin","year":"2000","journal-title":"J Biol Chem"},{"key":"R13-22-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000020504","article-title":"Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats.","volume":"6","author":"Yang","year":"1998","journal-title":"Exp Nephrol"},{"key":"R14-22-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/080370599438392","article-title":"Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet.","volume":"8","author":"Mervaala","year":"1999","journal-title":"Blood Press"},{"key":"R15-22-20210129","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ki.1997.380","article-title":"Angiotensin II blockade decreases TGF-b1 and matrix proteins in cyclosporine nephropathy.","volume":"52","author":"Shihab","year":"1997","journal-title":"Kidney Int"},{"key":"R16-22-20210129","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1523-1755.1999.00597.x","article-title":"Losartan decreases plasma levels of TGF-b1 in transplant patients with chronic allograft nephropathy.","volume":"56","author":"Campistol","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl","key":"R17-22-20210129","first-page":"SS5","article-title":"Mechanisms of nephrotoxicity.","volume":"69","author":"Campistol","year":"2000","journal-title":"Transplantation"},{"key":"R18-22-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporine: a randomised trial.","volume":"354","author":"Rahn","year":"1999","journal-title":"The Lancet"},{"key":"R19-22-20210129","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00007890-199110000-00012","article-title":"Improved outcome of cadaveric renal transplantation due to calcium channel blockers.","volume":"52","author":"Palmer","year":"1991","journal-title":"Transplantation"},{"key":"R20-22-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":"Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney Int"},{"key":"R21-22-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.HYP.26.3.436","article-title":"Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients.","volume":"26","author":"Sennesael","year":"1995","journal-title":"Hypertension"},{"key":"R22-22-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney Int"},{"key":"R23-22-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0006-291X(03)00158-X","article-title":"Antioxidant activity of different dihydropyridines.","volume":"302","author":"Cominacini","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-22-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0006-2952(00)00548-7","article-title":"Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.","volume":"61","author":"Sobala","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R25-22-20210129","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"R26-22-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/hy0202.103482","article-title":"Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury.","volume":"39","author":"Park","year":"2002","journal-title":"Hypertension"},{"key":"R27-22-20210129","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/00004872-199917121-00009","article-title":"Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells.","volume":"17","author":"Cominacini","year":"1999","journal-title":"J Hypertens"},{"key":"R28-22-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000045247","article-title":"Lacidipine protects against cyclosporine-induced nephrotoxicity in rats.","volume":"81","author":"Naidu","year":"1999","journal-title":"Nephron"},{"key":"R29-22-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0272-6386(99)70299-4","article-title":"Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine.","volume":"33","author":"Fassi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R30-22-20210129","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0895-7061(02)03000-5","article-title":"Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.","volume":"15","author":"Leonetti","year":"2002","journal-title":"Am J Hypertens"},{"key":"R31-22-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5414\/CPP39325","article-title":"Semipersonalized psychological evaluation of quality of life in hypertensive patients during a trial with two calcium antagonits: a multicenter Latin-American Study (LASTLHY).","volume":"39","author":"Velasco","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R32-22-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11886-002-0110-9","article-title":"Vasodilatory edema: a common side effect of antihypertensive therapy.","volume":"4","author":"Messerli","year":"2002","journal-title":"Curr Cardiol Rep"},{"key":"R33-22-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1681\/ASN.V92310","article-title":"Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.","volume":"9","author":"Gaspari","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R34-22-20210129","first-page":"26","article-title":"Measurement of renal clearance of inulin and PAH in the steady state without urine collection.","volume":"13","author":"Schnurr","year":"1980","journal-title":"Clin Nephrol"},{"key":"R35-22-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"R36-22-20210129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1681\/ASN.V25983","article-title":"Verapamil improves the outcome after cadaveric renal transplantation.","volume":"2","author":"Dawidson","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"R37-22-20210129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00024382-199709000-00006","article-title":"Calcium blockade reduces renal apoptosis during ischemia reperfusion.","volume":"8","author":"Raafat","year":"1997","journal-title":"Shock"},{"issue":"Suppl 10","key":"R38-22-20210129","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/00005344-198710100-00058","article-title":"Prevention of delayed graft function on cadaver kidney transplants by diltiazem: outcome of two prospective, randomised clinical trials.","volume":"10","author":"Neumayer","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"R39-22-20210129","doi-asserted-by":"crossref","first-page":"72A","DOI":"10.1016\/0002-9149(87)90180-9","article-title":"Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused kidney.","volume":"59","author":"Loutzenhisuer","year":"1987","journal-title":"Am J Cardiol"},{"key":"R40-22-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI118125","article-title":"Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.","volume":"96","author":"Griffin","year":"1995","journal-title":"J Clin Invest"},{"key":"R41-22-20210129","first-page":"307","article-title":"Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.","volume":"48","author":"Ahmed","year":"1997","journal-title":"Clin Nephrol"},{"key":"R42-22-20210129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/ndt\/12.3.480","article-title":"Effects of the calcium antagonist felodipine on renal haemodynamics, tubular sodium handling, and blood pressure in cyclosporine-treated dermatological patients.","volume":"12","author":"Madsen","year":"1997","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000137793.23371.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:37:06Z","timestamp":1785850626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200410270-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,27]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000137793.23371.42","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10,27]]}}}